Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

Third quarter 2024 results

Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session. 

Friday October 25, 2024
14:00 - 15:30 CET (8:00am – 9:30am EST)

Upcoming Events

25Oct

2024

Third quarter 2024 results

Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.

14:00 - 15:30 CET (8:00am – 9:30am EST)

Quarterly Results

Discover more

30Jan

2025

Fourth Quarter & Full Year 2024 Results

Fourth quarter and full year 2024 results will be reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Quarterly Results

24Apr

2025

First Quarter 2025

First quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on April 24, 2025. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EDT)

Quarterly Results

Press Releases

October 11, 2024
Press Release: Sanofi in discussions to sell a controlling stake in Opella
October 9, 2024
Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants
September 27, 2024
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

2023 20-F

Presenting our 2023 FORM 20-F.

Subscribe to investor email alerts

Sign up to receive email alerts for various types of investor content

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com